Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

August 01, 1986; Volume 30,Issue 2
  • You have access
    Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    P Puttfarcken, L L Werling, S R Brown, T E Cote and B M Cox
    Molecular Pharmacology August 1986, 30 (2) 81-89;
  • You have access
    Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes.
    L L Werling, S R Brown, P Puttfarcken and B M Cox
    Molecular Pharmacology August 1986, 30 (2) 90-95;
  • You have access
    Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    A B Norman and I Creese
    Molecular Pharmacology August 1986, 30 (2) 96-103;
  • You have access
    Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockade.
    K A Neve and P B Molinoff
    Molecular Pharmacology August 1986, 30 (2) 104-111;
  • You have access
    Inhibition of chemotactic factor-activated Na+/H+ exchange in human neutrophils by analogues of amiloride: structure-activity relationships in the amiloride series.
    L Simchowitz and E J Cragoe
    Molecular Pharmacology August 1986, 30 (2) 112-120;
  • You have access
    Single-site model of the neuronal 5-hydroxytryptamine uptake and imipramine-binding site.
    J O Marcusson, I T Bäckström and S B Ross
    Molecular Pharmacology August 1986, 30 (2) 121-128;
  • You have access
    Brevetoxins, unique activators of voltage-sensitive sodium channels, bind to specific sites in rat brain synaptosomes.
    M A Poli, T J Mende and D G Baden
    Molecular Pharmacology August 1986, 30 (2) 129-135;
  • You have access
    Uracil nucleotide synthesis in a human breast cancer cell line (MCF-7) and in two drug-resistant sublines that contain increased levels of enzymes of the de novo pyrimidine pathway.
    J M Karle, K H Cowan, C A Chisena and R L Cysyk
    Molecular Pharmacology August 1986, 30 (2) 136-141;
  • You have access
    Cross-resistance of nocodazole-resistant mutants of CHO cells toward other microtubule inhibitors: similar mode of action of benzimidazole carbamate derivatives and NSC 181928 and TN-16.
    R S Gupta
    Molecular Pharmacology August 1986, 30 (2) 142-148;
  • You have access
    Inhibitory action of 10-deazaaminopterins and their polyglutamates on human thymidylate synthase.
    T Ueda, G E Dutschman, M G Nair, J I Degraw, F M Sirotnak and Y C Cheng
    Molecular Pharmacology August 1986, 30 (2) 149-153;
  • You have access
    Disposition of homocysteine and S-3-deazaadenosylhomocysteine in cells exposed to 3-deazaadenosine.
    A Svardal, R Djurhuus and P M Ueland
    Molecular Pharmacology August 1986, 30 (2) 154-158;
  • You have access
    Homogeneous uridine kinase from Ehrlich ascites tumor: substrate specificity and inhibition by bisubstrate analogs.
    N Cheng, R C Payne, W E Kemp and T W Traut
    Molecular Pharmacology August 1986, 30 (2) 159-163;
  • You have access
    Inhibition of multiple trans-sarcolemmal cation flux pathways by dichlorobenzamil in cultured chick heart cells.
    D Kim and T W Smith
    Molecular Pharmacology August 1986, 30 (2) 164-170;
  • You have access
    Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis.
    S Jard, R C Gaillard, G Guillon, J Marie, P Schoenenberg, A F Muller, M Manning and W H Sawyer
    Molecular Pharmacology August 1986, 30 (2) 171-177;
  • You have access
    Differences in the mechanism of functional interaction between NADPH-cytochrome P-450 reductase and its redox partners.
    P P Tamburini and J B Schenkman
    Molecular Pharmacology August 1986, 30 (2) 178-185;
  • You have access
    Proenkephalin-A gene regulation in the rat striatum: influence of lithium and haloperidol.
    S P Sivam, C Strunk, D R Smith and J S Hong
    Molecular Pharmacology August 1986, 30 (2) 186-191;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 30, Issue 2
1 Aug 1986
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Nelfinavir and PXR
  • Wnt Signaling and Drug Resistance in Cancer
  • Coronavirus in the Brain and the Impact of Smoking
  • Arginine-259 of UGT2B7 Confers UDP-Sugar Selectivity
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics